Biohaven Total Current Assets vs Intangible Assets Analysis
| BHVN Stock | USD 38.97 0.43 1.12% |
Biohaven Pharmaceutical financial indicator trend analysis is way more than just evaluating Biohaven Pharmaceutical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biohaven Pharmaceutical is a good investment. Please check the relationship between Biohaven Pharmaceutical Total Current Assets and its Intangible Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Total Current Assets vs Intangible Assets
Total Current Assets vs Intangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biohaven Pharmaceutical Total Current Assets account and Intangible Assets. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Biohaven Pharmaceutical's Total Current Assets and Intangible Assets is -0.63. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Biohaven Pharmaceutical Holding, assuming nothing else is changed. The correlation between historical values of Biohaven Pharmaceutical's Total Current Assets and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Biohaven Pharmaceutical Holding are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Total Current Assets i.e., Biohaven Pharmaceutical's Total Current Assets and Intangible Assets go up and down completely randomly.
Correlation Coefficient | -0.63 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Most indicators from Biohaven Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biohaven Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. As of the 29th of April 2024, Enterprise Value is likely to grow to about 3.2 B, while Selling General Administrative is likely to drop about 61 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 1.4M | 1.4M | 6.9M | 7.3M | Cost Of Revenue | 91.7M | 1.4M | 3.4M | 3.2M |
Biohaven Pharmaceutical fundamental ratios Correlations
Click cells to compare fundamentals
Biohaven Pharmaceutical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biohaven Pharmaceutical fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 344.3M | 111.5M | 142.1M | 661.8M | 513.2M | 347.2M | |
| Other Current Liab | 52.1M | 27.1M | 37.2M | 79.3M | 36.5M | 38.6M | |
| Total Current Liabilities | 66.2M | 29.9M | 41.9M | 90.0M | 55.4M | 49.1M | |
| Total Stockholder Equity | (7.4M) | 16.8M | 34.7M | 538.8M | 428.0M | 449.4M | |
| Property Plant And Equipment Net | 8.2M | 13.6M | 18.2M | 52.4M | 48.6M | 51.0M | |
| Net Debt | (316.7M) | 185.0M | 550.7M | (174.3M) | (218.8M) | (207.9M) | |
| Retained Earnings | (972.4M) | (1.7B) | (2.6B) | (91.1M) | (499.3M) | (524.3M) | |
| Accounts Payable | 14.1M | 2.8M | 4.8M | 10.7M | 15.6M | 10.0M | |
| Cash | 316.7M | 82.5M | 76.1M | 204.9M | 249.7M | 151.5M | |
| Non Current Assets Total | 16.0M | 21.7M | 47.2M | 74.8M | 70.8M | 40.6M | |
| Non Currrent Assets Other | 7.8M | 1.0M | 3.2M | 2.6M | 2.4M | 4.2M | |
| Cash And Short Term Investments | 316.7M | 82.5M | 76.1M | 465.3M | 383.1M | 270.2M | |
| Liabilities And Stockholders Equity | 344.3M | 111.5M | 142.1M | 661.8M | 513.2M | 347.2M | |
| Non Current Liabilities Total | 285.5M | 4.8M | 5.4M | 33.0M | 29.8M | 55.3M | |
| Other Current Assets | 11.6M | 10K | 2.1M | 19.3M | 45.7M | 47.9M | |
| Other Stockholder Equity | 83.5M | 98.9M | 169.7M | 13.9M | 39.8M | 73.8M | |
| Total Liab | 351.7M | 34.7M | 47.4M | 123.0M | 85.2M | 91.0M | |
| Total Current Assets | 328.3M | 89.8M | 94.8M | 587.0M | 442.4M | 306.6M | |
| Common Stock | 881.4M | 1.2B | 1.7B | 615.7M | 887.5M | 970.6M |
Biohaven Pharmaceutical Investors Sentiment
The influence of Biohaven Pharmaceutical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Biohaven. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Biohaven Pharmaceutical's public news can be used to forecast risks associated with an investment in Biohaven. The trend in average sentiment can be used to explain how an investor holding Biohaven can time the market purely based on public headlines and social activities around Biohaven Pharmaceutical Holding. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biohaven Pharmaceutical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biohaven Pharmaceutical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Biohaven Pharmaceutical's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Biohaven Pharmaceutical.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biohaven Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biohaven Pharmaceutical's short interest history, or implied volatility extrapolated from Biohaven Pharmaceutical options trading.
Pair Trading with Biohaven Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biohaven Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Biohaven Stock
| 0.68 | DRRX | Durect Earnings Call This Week | PairCorr |
| 0.68 | ELAN | Elanco Animal Health Financial Report 14th of May 2024 | PairCorr |
Moving against Biohaven Stock
| 0.42 | ACB | Aurora Cannabis Downward Rally | PairCorr |
The ability to find closely correlated positions to Biohaven Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biohaven Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biohaven Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biohaven Pharmaceutical Holding to buy it.
The correlation of Biohaven Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biohaven Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biohaven Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biohaven Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Biohaven Stock analysis
When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Biohaven Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.73) | Return On Assets (0.46) | Return On Equity (0.84) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.